SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 166,134 shares at $25.12 ($4.2M) on 2023-04-19, disclosed to the SEC on 2023-04-20.
Open-market sale of $4.2M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.12 | 6,953 | $175K | 4.2% |
| 2 | $25.12 | 6,953 | $175K | 4.2% |
| 3 | $25.12 | 76,114 | $1.9M | 45.8% |
| 4 | $25.12 | 76,114 | $1.9M | 45.8% |
| Total | $25.12 avg | 166,134 | $4.2M | 100% |
| Filing → |
| VIR | SELL | 2025-10-30 | $319K | — | Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |